Social Determinants of Health in Newly Diagnosed Hereditary Angioedema and Their Impact on Healthcare Resource Utilization Outcomes
The Journal of Allergy and Clinical Immunology: In Practice · 2026-08 · 14 (8) · 1869-1880.e7
DOI: 10.1016/j.jaip.2026.06.008 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026-08. Verfasst von Alan P Baptist und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Clinical Immunology, Henry Ford Health and Michigan State University, Detroit, Mich. Hauptthemen laut MEDLINE: Angioedemas, Hereditary, Social Determinants of Health, Patient Acceptance of Health Care. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Takeda Pharmaceuticals USA Inc, Takeda Pharmaceuticals U.S.A..
Abstract (Originalsprache)
BACKGROUND: Hereditary angioedema (HAE) is a rare disease characterized by unpredictable, painful swelling attacks. Social determinants of health may affect healthcare resource utilization (HCRU) for HAE attacks. OBJECTIVE: Estimate HCRU among patients with HAE analyzed by race and ethnicity, household income, and rural/urban residency. METHODS: This retrospective, observational study used healthcare insurance claims data (January 1, 2016, to September 30, 2023) from Inovalon's closed claims database. Eligible patients had a new HAE diagnosis or treatment claim (first claim defined index date), no previous claim in previous 12 months' continuous health plan enrollment, maintained 24-month continuous enrollment post-index, and were not using angiotensin-converting enzyme inhibitors. RESULTS: Multivariable models and HAE-related HCRU data revealed that patients from lower-income households (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Allergy and Clinical Immunology, Henry Ford Health and Michigan State University, Detroit, Mich.
- Division of Pediatric Allergy and Immunology, University of Alabama, Birmingham, Ala.
- Division of Allergy and Immunology, Department of Medicine, University of California San Diego, La Jolla, Calif.
- Inovalon Insights, Bowie, Md.
- Takeda Pharmaceuticals USA, Inc., Lexington, Mass.
- Takeda Pharmaceuticals USA, Inc., Lexington, Mass. Electronic address: robert.schultz@takeda.com.
Förderung
- Takeda Pharmaceuticals USA Inc
- Takeda Pharmaceuticals U.S.A.
Zitieren
APA
Baptist, A. P., Meadows, J. A., Riedl, M. A., Davis, T., Robinson, S. B., Huang, Y., Mohammadi, I., Sing, K., Fox, D., Schultz, B. G., & Juethner, S. (2026). Social Determinants of Health in Newly Diagnosed Hereditary Angioedema and Their Impact on Healthcare Resource Utilization Outcomes. The Journal of Allergy and Clinical Immunology: In Practice, 14(8), 1869-1880.e7. https://doi.org/10.1016/j.jaip.2026.06.008
Vancouver
Baptist AP, Meadows JA, Riedl MA, Davis T, Robinson SB, Huang Y, et al. Social Determinants of Health in Newly Diagnosed Hereditary Angioedema and Their Impact on Healthcare Resource Utilization Outcomes. The Journal of Allergy and Clinical Immunology: In Practice. 2026;14(8):1869-1880.e7. doi:10.1016/j.jaip.2026.06.008
BibTeX
@article{Baptist2026,
author = {Baptist, Alan P and Meadows, J Allen and Riedl, Marc A and Davis, Tigwa and Robinson, Scott B and Huang, Yecheng and Mohammadi, Iman and Sing, Krystal and Fox, Daniel and Schultz, Bob G and Juethner, Salomé},
title = {Social Determinants of Health in Newly Diagnosed Hereditary Angioedema and Their Impact on Healthcare Resource Utilization Outcomes},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
volume = {14},
number = {8},
pages = {1869--1880.e7},
doi = {10.1016/j.jaip.2026.06.008}
}
EUVIMED